Medicine and Dentistry
(3 Iodobenzyl)guanidine
50%
(3 Iodobenzyl)guanidine I 131
83%
Biodistribution
6%
Bystander Effect
50%
Clinical Trial
16%
Combination Therapy
50%
DNA Damage
16%
Dose Calculation
50%
Dose Response
8%
Expression Vector
6%
Gamma Irradiation
58%
Ganglioglioma
6%
Ganglioneuroblastoma
16%
Halogen
6%
In Vitro
16%
Intrinsic Clearance
6%
Iodine 131
50%
Malignant Neoplasm
8%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
50%
Noradrenalin
91%
Norepinephrine Transporter
9%
Nuclear Imaging
6%
Olaparib
12%
Patient
16%
Poly ADP Ribose Polymerase
50%
Poly ADP Ribose Polymerase
16%
Programmed Cell Death
8%
Radiation
25%
Radiation Therapy
33%
Radiopharmaceutical Agent
8%
Spontaneous Remission
16%
Therapeutic Modality
6%
Therapeutic Procedure
41%
Topoisomerase Inhibitor
16%
Topotecan
50%
Toxicity
50%
Xenograft
50%
Pharmacology, Toxicology and Pharmaceutical Science
(3 Iodobenzyl)guanidine I 131
6%
Colorectal Cancer
6%
Copper
50%
Cytotoxicity
9%
Disulfiram
100%
Element
6%
Gamma Irradiation
8%
Glioma
9%
Iobenguane
40%
Malignant Neoplasm
50%
Neoplasm
15%
Neuroendocrine Tumor
6%
Noradrenalin
56%
Proteasome
6%
Radiation
53%
Radioisotope
53%
Radiopharmaceutical Agent
15%
Radiosensitizing Agent
6%
Toxicity
50%